Personalized Chemotherapy of Tumor Disease Based on System Modeling

Clinically, personalized medicine also referred to as precision medicine is a new medical model to be directly tailored for the care of individual patients. It is often called "the right treatment for the right person at the right time." Most successful examples of personalized treatments require a rational clinical genomic analysis. Following Research and Development (R&D) of techniques and analysis of clinical genomic expression, genomic expression profile along with system modeling has been increasingly applied for personalized therapy. Now personalized chemotherapy, one of personalized therapy, has been brought forward to the field of cancer. According to protocol of personalized chemotherapy from tumor tissue sampling to clinical application in queue, I will introduce the entire process including clinical sampling, analyzing mRNA genomic expression level with its diagnosis, discovering gene expression signature by system modeling and uncovering sensitive drugs from drugbank for clinical application. At present, after next-generation sequencing is brought into the new field, system modeling related with drugs discovery will make great contribution for future personalized chemotherapy of tumor diseases.

Keywords: Cancer stem cells (CSCs), Circulating tumor cells (CTCs), Clinical genomics analysis, Clinical genomic diagnosis, Drug targeting, Encyclopedia of DNA Elements (ENCODE), Flow-cytometric cell sorting (FACS), Gene expression signature (GES), Genome-wide association studies (GWAS), Lasercaptured micro-dissection (LCM), Magnetic cell separation (MACS), Networks, Personalized chemotherapy, Personalized medicine, Proteomics, Single nucleotide polymorphisms (SNP), System biology and system modeling, Transcriptome.